News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Derma Sciences, Inc. (DSCI) Reports 2012 Fourth Quarter and Full Year Financial Results


4/1/2013 6:25:01 AM

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the fourth quarter and year ended December 31, 2012. Highlights of the fourth quarter of 2012 and recent weeks include:

•Net sales were $20.1 million in the fourth quarter of 2012, up 22% over the prior-year fourth quarter and up 2% sequentially; net sales for the year were $72.6 million, up 16% over 2011

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES